Abstract
Introduction: A reverse-phase high-performance liquid chromatography (RP-HPLC) method was developed and validated for the simultaneous analysis of two drugs, levamisole hydrochloride (LH) and oxyclozanide (OX), in co-formulation for veterinary use.
Materials and Methods: The new HPLC method was validated as per the ICH and other guidelines. A C18 column was used with a gradient program; eluent A was an equal mixture of methanol and acetonitrile, and eluent B included a 25 mM phosphate buffer at pH 7.0 containing 30 mM sodium decanesulfonate and triethylamine (50:50:1 v/v) with pH adjusted to 7.0 using H3PO4 [51:49 v/v] .The detection wavelength was set at 220 nm. For the final gradient program, the retention times were 8.2(for LH) and 13.6(for OX) minutes, respectively, at a flow rate of 1 ml/min over 20 minutes run time.
Results: The method was precise, specific and robust. The correlation coefficient, R2 was 0.9998 and 0.9999 for LH and OX, respectively in the range of 5 – 280 μg / mL. The percent y-intercepts and percent residual standard deviations were 1.6%/0.4% and 1.4%/1.0% for LH and OX, respectively. The LOD and LOQ of the method were 0.21 μg / mL and 0.62 μg / mL for LH and 0.06 μg / mL and 0.18 μg / mL for OX. The method has an average accuracy of 100.5% for LH and 101.1% for OX when tested on veterinary bolus formulations, and the samples could be stored under typical lab conditions for about 7 days without significant degradation.
Conclusion: This HPLC method is suitable for assaying levamisole hydrochloride and oxyclozanide simultaneously from veterinary formulations.
Keywords: Analytical method development, bolus formulations, RP-HPLC, levamisole, oxyclozanide, imidazothiazole.
Graphical Abstract
[http://dx.doi.org/10.1021/jf0102362] [PMID: 11743750]
[http://dx.doi.org/10.1038/210744a0] [PMID: 6006650]
[http://dx.doi.org/10.1016/j.jchromb.2003.08.025] [PMID: 14581076]
[http://dx.doi.org/10.1016/S0731-7085(00)00513-6] [PMID: 11377020]
[http://dx.doi.org/10.1080/10826070701739132]
[http://dx.doi.org/10.1016/S0378-4347(00)00171-7] [PMID: 10901133]
[http://dx.doi.org/10.1016/S0003-2670(02)01377-6]
[http://dx.doi.org/10.1016/j.jchromb.2010.11.015] [PMID: 21256094]
[http://dx.doi.org/10.1016/j.snb.2006.05.018]
[http://dx.doi.org/10.1016/S0731-7085(99)00269-1] [PMID: 10719905]
[http://dx.doi.org/10.1016/S0731-7085(00)00459-3] [PMID: 11274852]
[http://dx.doi.org/10.1016/S0731-7085(99)00240-X] [PMID: 10727118]
[http://dx.doi.org/10.5625/lar.2011.27.1.37] [PMID: 21826158]
[http://dx.doi.org/10.1016/0021-9673(95)01253-2]
[http://dx.doi.org/10.1021/jf102725b] [PMID: 21058728]
[http://dx.doi.org/10.1016/j.chroma.2010.05.007] [PMID: 20564781]
[http://dx.doi.org/10.1016/j.aca.2008.10.072] [PMID: 19286030]
[http://dx.doi.org/10.1016/j.chroma.2009.07.036] [PMID: 19656518]
[http://dx.doi.org/10.1002/9781118592014]
[http://dx.doi.org/10.1016/S0149-6395(07)80022-5]
[http://dx.doi.org/10.1016/S0149-6395(05)80046-7]